Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

NAActive, not recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

January 17, 2018

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Heart Failure
Interventions
DEVICE

WiSE System

The WiSE System is an implantable cardiac system to provide LV pacing stimulation in conjunction with a co-implanted system that provides right ventricular stimulation.

Trial Locations (68)

2031

Prince of Wales Hospital, Randwick

2050

Royal Prince Alfred Hospital, Camperdown

2305

John Hunter Hospital, New Lambton Heights

2605

Canberra Hospital, Garran

3168

Monash Heart, Clayton

5000

Royal Adelaide Hospital, Adelaide

6150

Fiona Stanley Hospital, Perth

10065

Weill Cornell Medical Center, New York

15213

UPMC Heart and Vascular Institute, Pittsburgh

16321

Immanuel Klinikum Bernau - Herzzentrum Brandenburg, Bernau

17033

Penn State Health, Hershey Medical Center, Hershey

22903

University of Virginia, Charlottesville

23507

Sentara Healthcare, Norfolk

29425

MUSC Gazes Research Institute, Charleston

30309

Piedmont Heart Institute, Atlanta

30322

Emory Healthcare, Atlanta

32204

St. Vincent's Healthcare, Jacksonville

33316

Broward Health Medical Center, Fort Lauderdale

33709

Northside Hospital and Heart Institute, St. Petersburg

33805

Watson Clinic, Lakeland

34102

Naples Community Hospital, Naples

35801

Heart Center Research, Huntsville

38138

Stern Cardiovascular Center, Germantown

40138

Policlinico S. Orsola, Bologna

40503

Baptist Health Lexington, Lexington

43210

The Ohio State University, Columbus

44195

Cleveland Clinic, Cleveland

46290

St. Vincent's Hospital and Healthcare Center, Indianapolis

48030

William Beaumont Hospital, Hazel Park

48109

University of Michigan, Ann Arbor

48188

Michigan Heart, Canton

48202

Henry Ford Hospital, Detroit

48912

Sparrow Hospital, Lansing

52242

University of Iowa, Iowa City

53215

Aurora St. Luke's Medical Center, Milwaukee

55102

United Heart and Vascular Clinic, Saint Paul

55407

Minneapolis Heart Institute, Minneapolis

55905

Mayo Clinic, Rochester

62769

Prairie Heart, Springfield

63131

Saint Luke's Health System Kansas City, Kansas City

66160

The University of Kansas Medical Center, Kansas City

68114

Methodist Physicians Clinic Heart Consultants, Omaha

70816

Ochsner Medical Center - Baton Rouge, Baton Rouge

75093

The Heart Hospital Baylor Plano, Plano

77030

Texas Heart Institute, Houston

The University of Texas Health Science Center at Houston, Houston

77479

Houston Methodist, Sugar Land

84107

Intermountain Medical Center, Murray

91054

Universitätsklinikum Erlangen, Erlangen

92037

University of California, San Diego, La Jolla

97477

PeaceHealth, Springfield

08901

Rutgers University, New Brunswick

08240

AtlantiCare Regional Medical Center, Pomona

Unknown

Sydney Adventist Hospital, Wahroonga

The Prince Charles Hospital, Chermside

Royal Melbourne Hospital / Royal Hobart Hospital, Parkville

CHU Grenoble - Hopital Michallon Service de Cardiologie, Grenoble

Centre Cardiologique du Nord, Paris

CHU-Hopital Pontchaillou, Rennes

Universitäres Herzzentrum Hamburg (UKE Hamburg) GmbH (UHZ), Hamburg

Ospedale San Gerardo, Monza

8025 AB

Isala Hartcentrum, Zwolle

L14 3PE

Liverpool Heart and Chest Hospital, Liverpool

EC1A 7BE

Barts Heart Centre, London

SE1 7EH

St. Thomas Hospital, London

M13 9WL

Manchester Heart Centre, Manchester

TS4 3BW

James Cook University Hospital, Middlesbrough

OX3 9DU

John Radcliffe Hospital, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

EBR Systems, Inc.

INDUSTRY

NCT02922036 - Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients | Biotech Hunter | Biotech Hunter